simvastatin acid

solute carrier organic anion transporter family member 1B1 ; Homo sapiens







12 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 30348903 Mechanistic In Vitro Studies Indicate that the Clinical Drug-Drug Interaction between Telithromycin and Simvastatin Acid Is Driven by Time-Dependent Inhibition of CYP3A4 with Minimal Effect on OATP1B1. 2019 Jan 2
2 29469964 Impact of SLCO1B1 Genotype on Pediatric Simvastatin Acid Pharmacokinetics. 2018 Jun 2
3 28350522 The influences of SLCO1B1 and ABCB1 genotypes on the pharmacokinetics of simvastatin, in relation to CYP3A4 inhibition. 2017 Apr 2
4 25673568 Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect? 2015 Mar 2
5 26020121 SLCO1B1 polymorphism markedly affects the pharmacokinetics of lovastatin acid. 2015 Aug 1
6 26164721 Individual and Combined Associations of Genetic Variants in CYP3A4, CYP3A5, and SLCO1B1 With Simvastatin and Simvastatin Acid Plasma Concentrations. 2015 Jul 1
7 26329790 Clopidogrel Has No Clinically Meaningful Effect on the Pharmacokinetics of the Organic Anion Transporting Polypeptide 1B1 and Cytochrome P450 3A4 Substrate Simvastatin. 2015 Nov 1
8 26367500 Impact of CYP2D6, CYP3A5, CYP2C19, CYP2A6, SLCO1B1, ABCB1, and ABCG2 gene polymorphisms on the pharmacokinetics of simvastatin and simvastatin acid. 2015 Dec 1
9 22538052 Prediction of the in vivo OATP1B1-mediated drug-drug interaction potential of an investigational drug against a range of statins. 2012 Aug 30 1
10 21245207 Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake. 2011 Mar 3
11 19785645 Impact of OATP transporters on pharmacokinetics. 2009 Oct 6
12 17108811 SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid. 2006 Dec 4